What is the optimal tapering strategy for rituximab in patients with Rheumatoid Arthritis: comparison of interval prolongation with disease activity guided dose reduction
Project geleid door Patrick Verschueren (KU Leuven) : 'What is the optimal tapering strategy for rituximab in patients with Rheumatoid Arthritis: comparison of interval prolongation with disease activity guided dose reduction'
Ondersteuning
€ 20.990
Blijf op de hoogte van nieuwe ondersteunde individuen of organisaties